Cargando…

A phase II trial with rosiglitazone in liposarcoma patients

Agents of the thiazolidinedione drug family can terminally differentiate human liposarcoma cells in vitro by activating genes responsible for lipocyte differentiation. One study has shown clinical activity of troglitazone treatment in liposarcoma patients. We sought to find further evidence for this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debrock, G, Vanhentenrijk, V, Sciot, R, Debiec-Rychter, M, Oyen, R, Van Oosterom, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394353/ https://www.ncbi.nlm.nih.gov/pubmed/14562008 http://dx.doi.org/10.1038/sj.bjc.6601306

Ejemplares similares

A Sarcoma at the Site of Previous Extravasation of Adriamycin
por: Ceulemans, Joris, et al.
Publicado: (2002)

Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models()()()
por: Li, Haifu, et al.
Publicado: (2014)

A rare case of atypical/anaplastic meningioma with MDM2 amplification
por: Wylleman, Robbert, et al.
Publicado: (2018)

Cellular Angiofibroma of the Prostate: A Rare Tumor in an Unusual Location
por: Wyn, Inez, et al.
Publicado: (2014)

Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma
por: Przybyl, Joanna, et al.
Publicado: (2022)

Case report: Cardiac intimal sarcoma in a young child
por: Verbeek, Sanne, et al.
Publicado: (2023)

Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma
por: Wang, Yannick, et al.
Publicado: (2022)

Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma
por: Prenen, Hans, et al.
Publicado: (2015)

Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011)

Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases
por: Przybyl, Joanna, et al.
Publicado: (2012)

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
por: Komajda, Michel, et al.
Publicado: (2010)

Frequent activation of EGFR in advanced chordomas
por: Dewaele, Barbara, et al.
Publicado: (2011)

Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models()()
por: Van Looy, Thomas, et al.
Publicado: (2015)

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
por: Franceschi, E, et al.
Publicado: (2004)

Ecteinascidin-743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma Patients
por: Huygh, G., et al.
Publicado: (2006)

Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts
por: Cornillie, Jasmien, et al.
Publicado: (2019)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma
por: Haniball, J., et al.
Publicado: (2011)

Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 “CREATE” Trial
por: Lee, Che-Jui, et al.
Publicado: (2021)

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors
por: Wang, Yannick, et al.
Publicado: (2020)

Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial
por: Florez, H, et al.
Publicado: (2015)

Imaging of Skeletal Metastases in Myxoid Liposarcoma
por: Noble, J. L., et al.
Publicado: (2010)

Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
por: Atamer, Y., et al.
Publicado: (2013)

Retroperitoneal liposarcoma in a nonagenarian
por: Cheung, King Tung, et al.
Publicado: (2020)

Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma
por: Waters, J S, et al.
Publicado: (2004)

Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 “CREATE” Trial
por: Lee, Che-Jui, et al.
Publicado: (2022)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study
por: Riedel, Richard F., et al.
Publicado: (2020)

Prognostic Factors and Expression of MDM2 in Patients with Primary Extremity Liposarcoma
por: Júnior, Rosalvo Zósimo Bispo, et al.
Publicado: (2008)

Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer
por: Albrecht, W, et al.
Publicado: (2004)

Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM
por: Guclu, Metin, et al.
Publicado: (2015)

Phase II trial of imatinib mesylate in patients with metastatic melanoma
por: Kim, K B, et al.
Publicado: (2008)

Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial
por: Köhne, C-H, et al.
Publicado: (2003)

Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
por: Keung, Emily Z., et al.
Publicado: (2018)

Abdominal Actinomycosis misdiagnosed as liposarcoma
por: Monteiro, Eunice Vieira e, et al.
Publicado: (2019)

Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors
por: Van Looy, Thomas, et al.
Publicado: (2014)

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
por: Bengala, C, et al.
Publicado: (2010)

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group
por: Peyser, Alexandra, et al.
Publicado: (2010)

Eribulin in Patients with Liposarcoma and Leiomyosarcoma: A Retrospective Single-Center Experience
por: Steinbrecher, Oskar, et al.
Publicado: (2023)

Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lsm0a4mi68n1opvv4r3d8p7c2i